BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11405518)

  • 1. IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis.
    Maier LA; Sawyer RT; Tinkle SS; Kittle LA; Barker EA; Balkissoon R; Rose C; Newman LS
    Eur Respir J; 2001 Mar; 17(3):403-15. PubMed ID: 11405518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease.
    Tinkle SS; Schwitters PW; Newman LS
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):969-71. PubMed ID: 8933043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beryllium induces IL-2 and IFN-gamma in berylliosis.
    Tinkle SS; Kittle LA; Schumacher BA; Newman LS
    J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
    Tinkle SS; Kittle LA; Newman LS
    J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP.
    Sawyer RT; Parsons CE; Fontenot AP; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):122-30. PubMed ID: 14975942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells.
    Amicosante M; Berretta F; Franchi A; Rogliani P; Dotti C; Losi M; Dweik R; Saltini C
    Eur Respir J; 2002 Nov; 20(5):1174-8. PubMed ID: 12449171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease.
    Tinkle SS; Newman LS
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1884-91. PubMed ID: 9412570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production.
    Dobis DR; Sawyer RT; Gillespie MM; Newman LS; Maier LA; Day BJ
    Am J Respir Cell Mol Biol; 2010 Oct; 43(4):458-64. PubMed ID: 19901345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease.
    Sawyer RT; Fontenot AP; Barnes TA; Parsons CE; Tooker BC; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Hagman J; Newman LS
    Am J Respir Cell Mol Biol; 2007 Feb; 36(2):191-200. PubMed ID: 16980557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.
    Day BJ; Huang J; Barkes BQ; Gillespie M; Li L; Maier LA
    Lung; 2018 Feb; 196(1):103-114. PubMed ID: 29080069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-presentation of beryllium by BAL CD4+ T cells: T cell-T cell interactions and their potential role in chronic beryllium disease.
    Fontenot AP; Edwards DM; Chou YK; Mack DG; LaTocha D; Vandenbark AA; Burrows GG
    Eur J Immunol; 2006 Apr; 36(4):930-9. PubMed ID: 16552706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.
    Mack DG; Lanham AM; Falta MT; Palmer BE; Maier LA; Fontenot AP
    Am J Respir Crit Care Med; 2010 Jun; 181(11):1241-9. PubMed ID: 20299529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease.
    Maier LA; Sawyer RT; Bauer RA; Kittle LA; Lympany P; McGrath D; Dubois R; Daniloff E; Rose CS; Newman LS
    Am J Respir Crit Care Med; 2001 Oct; 164(7):1192-9. PubMed ID: 11673208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beryllium-stimulated production of tumor necrosis factor-alpha by a mouse hybrid macrophage cell line.
    Sawyer RT; Kittle LA; Hamada H; Newman LS; Campbell PA
    Toxicology; 2000 Mar; 143(3):235-47. PubMed ID: 10755710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beryllium-stimulated apoptosis in macrophage cell lines.
    Sawyer RT; Fadok VA; Kittle LA; Maier LA; Newman LS
    Toxicology; 2000 Aug; 149(2-3):129-42. PubMed ID: 10967410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease.
    Maier LA; Kittle LA; Mroz MM; Newman LS
    Am J Ind Med; 2003 Jun; 43(6):592-601. PubMed ID: 12768609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease.
    Sawyer RT; Day BJ; Fadok VA; Chiarappa-Zucca M; Maier LA; Fontenot AP; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):470-7. PubMed ID: 15256386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease.
    Fontenot AP; Kotzin BL; Comment CE; Newman LS
    Am J Respir Cell Mol Biol; 1998 Apr; 18(4):581-9. PubMed ID: 9533947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beryllium increases the CD14(dim)CD16+ subset in the lung of chronic beryllium disease.
    Li L; Hamzeh N; Gillespie M; Elliott J; Wang J; Gottschall EB; Mroz PM; Maier LA
    PLoS One; 2015; 10(2):e0117276. PubMed ID: 25689051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta.
    Bost TW; Riches DW; Schumacher B; Carré PC; Khan TZ; Martinez JA; Newman LS
    Am J Respir Cell Mol Biol; 1994 May; 10(5):506-13. PubMed ID: 8179912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.